Compugen CEO Eran Ophir's Stock Option Exercise and Share Sale

On April 1, 2026, Eran Ophir, President and CEO of Compugen Ltd (CGEN), executed a coordinated stock transaction involving both option exercise and share sale. Ophir exercised options to acquire 5,625 ordinary shares at $0.8292 per share, increasing his direct holdings to 17,000 shares. Simultaneously, he sold the same 5,625 shares at a weighted average price of $2.2067 per share, reducing his direct holdings to 11,375 shares. The option exercised was part of a grant that vested 25% on December 31, 2023, with the remainder vesting in quarterly installments. The transaction was executed under a Rule 10b5-1 trading plan adopted on December 26, 2025, indicating pre-planned trading activity. Following these transactions, Ophir still holds 24,375 options. The coordinated exercise-and-sell transaction resulted in a net profit of approximately $7,750 from the price differential between the exercise price and sale price.